Supplement use and risk of cutaneous squamous cell carcinoma - 12/11/11
, Mary-Margaret Chren, MD b, c, E. Margaret Warton, MPH a, Gary D. Friedman, MD, MS a, d, Emily White, PhD e, f
Reprint requests: Maryam M. Asgari, MD, MPH, Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA 94612.Abstract |
Background |
Laboratory and epidemiologic studies suggest that certain dietary supplements may alter risk of cutaneous squamous cell carcinoma (SCC).
Objective |
We sought to examine the association between supplement use and SCC risk.
Methods |
Cases (n = 415) were defined as Kaiser Permanente Northern California members with a pathology-verified SCC in 2004 and control subjects (n = 415) were age-, sex-, and race-matched members with no history of skin cancer. Supplement use and SCC risk factors were ascertained by questionnaire. Associations of SCC with use of multivitamins; vitamins A, C, D, and E; and grape seed extract were estimated as odds ratios and 95% confidence intervals using conditional logistic regression. Models were adjusted for SCC risk factors and other supplement use.
Results |
Grape seed extract users had a significantly decreased risk of cutaneous SCC (adjusted odds ratio 0.26, confidence interval 0.08-0.89, P = .031). Multivitamin use was associated with a borderline significant reduction in SCC risk (adjusted odds ratio 0.71, confidence interval 0.51-1.00, P = .049). Use of vitamins A, C, D, and E was not associated with SCC risk.
Limitations |
The data may be prone to recall and selection bias because of the case-control design. No information was obtained on dose or duration of supplement use.
Conclusions |
Use of grape seed extract may be associated with a decreased risk of cutaneous SCC. The other supplements included in our study did not reveal clear associations with SCC risk.
Le texte complet de cet article est disponible en PDF.Key words : antioxidant, epidemiology, skin cancer, squamous cell carcinoma, supplement, vitamin
Abbreviations used : CI, GSE, IL, KPNC, MHS, OR, SCC
Plan
| Supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (K23 AR 051037 to Dr Asgari, K24 AR 052667 to Dr Chren) and by the National Cancer Institute (R01 CA 098838 to Dr Friedman, K05CA154337 to Dr White). |
|
| Conflicts of interest: None declared. |
Vol 65 - N° 6
P. 1145-1151 - décembre 2011 Retour au numéro
Article précédent
- Increased risk of infectious disease requiring hospitalization among patients with psoriasis: A population-based cohort
- Marlies Wakkee, Esther de Vries, Pieter van den Haak, Tamar Nijsten
- Expression of CD10 predicts tumor progression and unfavorable prognosis in malignant melanoma
- Junna Oba, Takeshi Nakahara, Sayaka Hayashida, Makiko Kido, Lining Xie, Masakazu Takahara, Hiroshi Uchi, Shogo Miyazaki, Takeru Abe, Akihito Hagihara, Yoichi Moroi, Masutaka Furue
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?